Actif À Court Terme Changement Date
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Baxter International USD 6.85B 25M 2026-03
Bio Path USD 677K 14K 2026-03
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12